Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. financial statements

Nurix Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 83.98M10-K
Net income−USD 264.46M10-K
Cash and equivalentsUSD 246.96M10-Q

Nurix Therapeutics, Inc. financials on 6ix · Nurix Therapeutics, Inc. on 6ix